Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial

BACKGROUND: Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex. The daily care of these patients can be difficult due to dystonic movements. Intrathecal baclofen treatment is a potential treatment option for dystonia and has become common practice. Despite...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Bonouvrié, Laura A, Becher, Jules G, Vles, Johannes SH, Boeschoten, Karin, Soudant, Dan, de Groot, Vincent, van Ouwerkerk, Willem JR, Strijers, Rob LM, Foncke, Elisabeth, Geytenbeek, Joke, van de Ven, Peter M, Teernstra, Onno, Vermeulen, R Jeroen
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Study Protocol
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3840690/
https://ncbi.nlm.nih.gov/pubmed/24165282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2431-13-175
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi